Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines

References

• Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020;9(1):275–277. doi: 10.1080/22221751.2020.1723441
   PubMed Web of Science ®Google Scholar
• Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020 Mar;25(3):278–280. doi: 10.1111/tmi.13383
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Weston S, Frieman MB. COVID-19: knowns, unknowns, and questions. mSphere. 2020 Mar 18;5(2):e00203-20. doi: 10.1128/mSphere.00203-20
   PubMed Web of Science ®Google Scholar
• Le T T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020 May;19(5):305–306. doi: 10.1038/d41573-020-00073-5
   PubMed Web of Science ®Google Scholar
• Padron-Regalado E. Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect Dis Ther. 2020 Apr 23;9(2):1–20. doi: 10.1007/s40121-020-00300-x
   PubMed Web of Science ®Google Scholar
• Plotkin SA. [New vaccination strategies]. Bull Acad Natl Med. 2008 Mar;192(3):511–518. discussion 8–9.
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Plotkin SL. The development of vaccines: how the past led to the future. Nat Rev Microbiol. 2011 Oct 3;9(12):889–893. doi: 10.1038/nrmicro2668
   PubMed Web of Science ®Google Scholar
• Sun J, Han Z, Shao Y, et al. Comparative proteome analysis of tracheal tissues in response to infectious bronchitis coronavirus, Newcastle disease virus, and avian influenza virus H9 subtype virus infection. Proteomics. 2014 Jun;14(11):1403–1423. doi: 10.1002/pmic.201300404
   PubMed Web of Science ®Google Scholar
• Zeng S, Zhang H, Ding Z, et al. Proteome analysis of porcine epidemic diarrhea virus (PEDV)-infected Vero cells. Proteomics. 2015 Jun;15(11):1819–1828. doi: 10.1002/pmic.201400458
   PubMed Web of Science ®Google Scholar
• Lin H, Li B, Chen L, et al. Differential protein analysis of IPEC-J2 cells infected with porcine epidemic diarrhea virus pandemic and classical strains elucidates the pathogenesis of infection. J Proteome Res. 2017 Jun 2;16(6):2113–2120. doi: 10.1021/acs.jproteome.6b00957
   PubMed Web of Science ®Google Scholar
• Choi S, Lee C. Functional characterization and proteomic analysis of porcine deltacoronavirus accessory protein NS7. J Microbiol Biotechnol. 2019 Nov 28;29(11):1817–1829. doi: 10.4014/jmb.1908.08013
   PubMed Web of Science ®Google Scholar
• Bojkova D, Klann K, Koch B, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020; In press.
   Web of Science ®Google Scholar
• Ortea I, Bock JO. Re-analysis of SARS-CoV-2 infected host cell proteomics time-course data by impact pathway analysis and network analysis. A potential link with inflammatory response; 2020. https://www.biorxiv.org/content/10.1101/2020.03.26.009605v1.
   Google Scholar
• Davidson AD, Williamson MK, Lewis S, et al. Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site; 2020. https://www.biorxiv.org/content/10.1101/2020.03.22.002204v1.
   Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045
   PubMedGoogle Scholar
• Hartmann EM, Allain F, Gaillard JC, et al. Taking the shortcut for high-throughput shotgun proteomic analysis of bacteria. Methods Mol Biol. 2014;1197:275–285. doi: 10.1007/978-1-4939-1261-2_16
   PubMedGoogle Scholar
• Pereira S, Malard V, Ravanat JL, et al. Low doses of gamma-irradiation induce an early bystander effect in zebrafish cells which is sufficient to radioprotect cells. PLoS One. 2014;9(3):e92974. doi: 10.1371/journal.pone.0092974
   PubMed Web of Science ®Google Scholar
• Perez-Riverol Y, Csordas A, Bai J, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019 Jan 8;47(D1):D442–DD50. doi: 10.1093/nar/gky1106
   PubMed Web of Science ®Google Scholar
• Gouveia D, Grenga L, Pible O, et al. Quick microbial molecular phenotyping by differential shotgun proteomics. Environ Microbiol. in press.
   Web of Science ®Google Scholar
• Rau A, Maugis-Rabusseau C. Transformation and model choice for RNA-seq co-expression analysis. Brief Bioinform. 2018 May 1;19(3):425–436.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Wickham H. Ggplot2: elegant graphics for data analysis. New York: Springer International Publishing; 2016; eBook ISBN 978-3-319-24277-4 10.1007/978-3-319-24277-4.
   Google Scholar
• Park WB, Kwon NJ, Choi SJ, et al. Virus isolation from the first patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020 Feb 24;35(7):e84. doi: 10.3346/jkms.2020.35.e84
   PubMed Web of Science ®Google Scholar
• Grenga L, Pible O, Armengaud J. Pathogen proteotyping: a rapidly developing application of mass spectrometry to address clinical concerns. Clinical Mass Spectrometry. 2019;14:9–17. doi: 10.1016/j.clinms.2019.04.004
   PubMedGoogle Scholar
• Karlsson R, Gonzales-Siles L, Boulund F, et al. Proteotyping: proteomic characterization, classification and identification of microorganisms–a prospectus. Syst Appl Microbiol. 2015 Jun;38(4):246–257. doi: 10.1016/j.syapm.2015.03.006
   PubMed Web of Science ®Google Scholar
• Tang T, Bidon M, Jaimes JA, et al. Coronavirus membrane fusion mechanism offers as a potential target for antiviral development. Antiviral Res. 2020 Apr 6;178:104792. doi: 10.1016/j.antiviral.2020.104792
   PubMed Web of Science ®Google Scholar
• Chew T, Noyce R, Collins SE, et al. Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production. Mol Immunol. 2009 Jan;46(3):393–399. doi: 10.1016/j.molimm.2008.10.010
   PubMed Web of Science ®Google Scholar
• Jiang XS, Tang LY, Dai J, et al. Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection. Mol Cell Proteomics. 2005 Jul;4(7):902–913. doi: 10.1074/mcp.M400112-MCP200
   PubMed Web of Science ®Google Scholar
• Gouveia D, Grenga L, Gaillard JC, et al. Shortlisting SARS-CoV-2 peptides for targeted studies from experimental data-dependent acquisition tandem mass spectrometry data. Proteomics. 2020 May 27: e2000107. doi: 10.1002/pmic.202000107
   PubMed Web of Science ®Google Scholar
• Benam KH, Villenave R, Lucchesi C, et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat Methods. 2016 Feb;13(2):151–157. doi: 10.1038/nmeth.3697
   PubMed Web of Science ®Google Scholar
• Weston S, Haupt R, Logue J, et al. FDA approved drugs with broad anti-coronaviral activity inhibit SARS-CoV-2 in vitro; 2020. https://www.biorxiv.org/content/10.1101/2020.03.25.008482v1.
   Google Scholar
• Jeon S, Ko M, Lee J, et al. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00819-20. doi: 10.1128/AAC.00819-20
   PubMed Web of Science ®Google Scholar
• Si L, Bai H, Rodas M, et al. Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics; 2020. https://www.biorxiv.org/content/10.1101/2020.04.13.039917v1.
   Google Scholar